During a public hearing to discuss medication reform, officials with the New York Gaming Commission heard arguments from both Thoroughbred and Standardbred interests regarding proposed new medication rules.
According to the Blood-Horse, the NYGC is considering adopting uniform medication rules that have been approved by the Racing Medication and Testing Consortium. These rules have been adopted by several states in the Mid-Atlantic region.
Representatives of the harness racing industry, including the U.S. Trotting Association, however, do not feel that there should be a uniform, or 'blanket' set of rules for both Standardbreds and Thoroughbreds. Their main concerns are in withdrawal times and threshold levels for clenbuterol and corticosteroids. Harness racing leaders feel that the current rules in place are effective.
“We've used (the medications) for 10 years or more, and we don't have a problem with them,” USTA president Phil Langley told the NYGC.
“Our breed is just so durable.”
Read more in the Blood-Horse
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2020 Paulick Report.